SCHEMBL903607

SCHEMBL903607

c1ccc2cc3nc4c(nc3cc2c1)-c1cccc2cccc-4c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
MAPK1 P28482 3/20 0.58
HSD17B10 Q99714 3/20 0.58
TP53 P04637 3/20 0.58
HPGD P15428 2/20 0.58
TSHR P16473 2/20 0.58
CASP1 P29466 2/20 0.58
CASP7 P55210 2/20 0.58
HIF1A Q16665 1/20 0.58
SMN1; SMN2 Q16637 5/20 0.56
CYP1A2 P05177 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.52
ATM Q13315 1/20 0.52
NQO2 P16083 1/20 0.50
KDM4E B2RXH2 2/20 0.49
LMNA P02545 1/20 0.49
TDP1 Q9NUW8 1/20 0.46
RPS6KB2 Q9UBS0 1/20 0.46
CES2 O00748 1/20 0.43
BCHE P06276 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29867529 1.00 ALDH1A1 (0.58) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL12874082 0.91 CYP1A2 (0.59) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL31187046 0.86 CYP1A2 (0.58) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL824394 0.86 CYP1A2 (0.58) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL13492291 0.83 CYP1A2 (0.53) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL824409 0.82 CYP1A2 (0.59) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL14211974 0.81 SMN1; SMN2 (0.55) ALDH1A1TP53HPGDSMN1; SMN2CYP1A2
SCHEMBL15672164 0.80 CYP1A2 (0.50) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL11728344 0.80 CYP1A2 (0.54) ALDH1A1MAPK1HSD17B10TP53HPGD
SCHEMBL31317539 0.79 CYP1A2 (0.49) ALDH1A1MAPK1HSD17B10TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638126-B1 NEGATIVE DISPERSION RETARDATION PLATE AND ACHROMATIC CIRCULAR POLARIZER CRYSOPTIX KK (JP) 2015-02-18 EP claimed
EP-2331655-B1 COMPOSITION OF ORGANIC COMPOUNDS, OPTICAL FILM AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2013-07-03 EP claimed
US-12552906-B2 Composition, optically anisotropic film, circularly polarizing plate, and display device FUJIFILM CORPORATION (JP) 2026-02-17 US disclosed
US-12436331-B2 Optically anisotropic film, circularly polarizing plate, and display device FUJIFILM CORPORATION (JP) 2025-10-07 US disclosed
US-12436326-B2 Optically anisotropic film, circularly polarizing plate, and display device FUJIFILM CORPORATION (JP) 2025-10-07 US disclosed
US-20250102718-A1 POLARIZING PLATE, APPARATUS, HEAD-MOUNTED DISPLAY, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND IMAGING SYSTEM FUJIFILM CORPORATION (JP) 2025-03-27 US disclosed
US-20250043184-A1 OPTICALLY ANISOTROPIC FILM AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2025-02-06 US disclosed
US-20240053511-A1 LIGHT ABSORPTION ANISOTROPIC FILM, MANUFACTURING METHOD OF LIGHT ABSORPTION ANISOTROPIC FILM, DISPLAY DEVICE, CAMERA, SENSOR, AND APPARATUS FUJIFILM CORPORATION (JP) 2024-02-15 US disclosed
US-20230273361-A1 OPTICALLY ANISOTROPIC FILM, CIRCULARLY POLARIZING PLATE, AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-08-31 US disclosed
US-20230273361-A1 OPTICALLY ANISOTROPIC FILM, CIRCULARLY POLARIZING PLATE, AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-08-31 US disclosed
US-20230273361-A1 OPTICALLY ANISOTROPIC FILM, CIRCULARLY POLARIZING PLATE, AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-08-31 US disclosed
US-20120099052-A1 RETARDER AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME CRYSOPTIX KK (JP) 2012-04-26 US disclosed
US-20120099052-A1 RETARDER AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME CRYSOPTIX KK (JP) 2012-04-26 US disclosed
WO-2012052950-A1 RETARDER AND LIQUID CRYSTAL DISPLAY COMPRISING THE SAME CRYSOPTIX KK (JP) 2012-04-26 WO disclosed
WO-2012044867-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 WO disclosed
US-20120081784-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 US disclosed
US-20120081784-A1 PATTERNED RETARDER CRYSOPTIX KK (JP) 2012-04-05 US disclosed
US-20100085521-A1 Composition of Organic Compounds, Optical Film and Method of Production Thereof CRYSOPTIX KK (JP) 2010-04-08 US disclosed
US-20100085521-A1 Composition of Organic Compounds, Optical Film and Method of Production Thereof CRYSOPTIX KK (JP) 2010-04-08 US disclosed
WO-2010020928-A2 COMPOSITION OF ORGANIC COMPOUNDS, OPTICAL FILM AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552906-B2 Composition, optically anisotropic film, circularly polarizing plate, and display device RCC1, CRY1, CRY2 ALDH1A1 3973/4885MAPK1 2808/4885HSD17B10 3808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.